Breaking News
0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details
Close

Haemonetics Corporation (HAE)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Haemonetics's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
58.70 -0.19    -0.32%
27/07 - Closed. Currency in USD ( Disclaimer )
After Hours
58.70
-0.00
-0.00%
16:10:00 - Real-time Data
Type:  Equity
Market:  United States
ISIN:  US4050241003 
CUSIP:  405024100
  • Volume: 628,011
  • Bid/Ask: 52.55 / 68.00
  • Day's Range: 58.11 - 58.92
Haemonetics 58.70 -0.19 -0.32%
IndustryMedical Equipment & Supplies
SectorHealthcare
Employees

2708

Equity Type

ORD

Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system. It also provides automated blood component and manual whole blood collection systems, such as MCS brand apheresis equipment to collect specific blood components from the donor; disposable whole blood collection and component storage sets; SafeTrace Tx and El-Dorado Donor donation and blood unit management systems; Hemasphere software that provides support for blood drive planning; and Donor Doc and e-Donor software to enhance the donor recruitment and retention. In addition, the company offers hospital products comprising TEG diagnostic systems that enables clinicians to assess the coagulation status of a patient at the point-of-care or laboratory setting; TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions; Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries; and BloodTrack, a suite of blood management and bedside transfusion solutions that combines software with hardware components, as well as an extension of the hospital’s blood bank information system. It markets and sells its products through direct sales force, independent distributors, and sales representatives. Haemonetics Corporation was founded in 1971 and is headquartered in Boston, Massachusetts.

Contact Information

Phone +1-781-8487100
Fax -

Top Executives

Name Age Since Title
Richard J. Meelia 72 2011 Non-Executive Independent Chairman of the Board
Mark W. Kroll 68 2006 Independent Director
Ellen M. Zane 69 2018 Independent Director
Charles J. Dockendorff 66 2014 Independent Director
Christopher A. Simon 57 2016 President, Chief Executive Officer, Director
William P. Burke 53 2016 Chief Financial Officer, Executive Vice President
Michelle L. Basil 49 2017 Executive Vice President, General Counsel
Catherine M. Burzik 70 2016 Independent Director
Robert E. Abernathy 66 2017 Independent Director
Claire Pomeroy 66 2019 Independent Director
Josep L. Llorens 59 2018 Senior Vice President - Global Manufacturing and Supply Chain
Anila Lingamneni 54 2020 Executive Vice President, Chief Technology Officer
Michael J. Coyle 59 2020 Independent Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

HAE Comments

Write your thoughts about Haemonetics Corporation
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Dick Henderson
Dick Henderson Apr 23, 2021 5:41PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Got 600 shares at 71,5 avg this week. I belive that -45% on shareprice was an overreaction. Management kept their guidance at ”8-10% US growth for next five years” also on 2nd of march 425 million dollars worth of senior notes was issued at 175$. Who ever is financing this must not be happy, therefore i see at least some sort of upside in the next 3 weeks.
mario cruz
mario cruz Apr 23, 2021 5:41PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
i got 450 and bought more but my avg is 72.5, the stock goes up soon, is for long term, have good fundamentals
mario cruz
mario cruz Apr 22, 2021 10:54AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
excellent time to buy and long term, have a great upside aprox more than 65%
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email